Q4 FY2024 · ended Jun 30, 2024 · Revenue $1.41M, +17.5% YoY · Filed Oct 25, 2024
Procyon Corporation (PCYN) files with the SEC under industry code 2834, Pharmaceutical Preparations. In Q4 of fiscal 2024, the quarter ended Jun 30, 2024, it reported revenue of $1.4 million and net income of $37,976. Free cash flow was $1,013. As of Jun 30, 2024 it held $326,143 in cash and investments and $319,876 in total debt.
Revenue
$1.41M
+17.5% vs year-ago quarter
Net income
$37,976
+407.0% vs year-ago quarter
Operating cash flow
$2,640
-99.1% vs year-ago quarter
Free cash flow
$1,013
-99.2% vs year-ago quarter
EPS
$0.01
+2237.7% vs year-ago quarter
Dividend per share
None
Shares outstanding
8.12M
+0.4% vs year-ago quarter
Net cash
$6,267
Q4 FY2024
Operating margin
0.6%
Q4 FY2024
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PCYN (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- CO
- Headquarters
- Clearwater, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 812306
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q4 FY2024 Jun 30, 2024 |
Q3 FY2024 Mar 31, 2024 |
Q2 FY2024 Dec 31, 2023 |
Q1 FY2024 Sep 30, 2023 |
Q4 FY2023 Jun 30, 2023 |
|---|---|---|---|---|---|
| Revenue | $1.4M | $1.2M | $1.2M | $1.2M | $1.2M |
| Operating income | $8,893 | -$81,792 | -$101,415 | -$57,391 | -$3,153 |
| Net income | $37,976 | -$102,788 | -$242,473 | -$33,855 | $7,491 |
| Diluted EPS | $0.01 | -$0.01 | -$0.03 | -$0.01 | $0.00 |
| Operating cash flow | $2,640 | $58,074 | -$126,550 | $4,585 | $278,706 |
| Free cash flow | $1,013 | $57,326 | -$134,682 | -$48,820 | $124,657 |
| Total assets | $3.2M | $3.2M | $3.2M | $3.4M | $3.6M |
| Total liabilities | $917,122 | $997,305 | $813,662 | $843,803 | $946,002 |
| Stockholders' equity | $2.3M | $2.2M | $2.4M | $2.6M | $2.6M |
| Cash and investments | $326,143 | $325,130 | $267,804 | $402,486 | $451,306 |
| Total debt | $319,876 | $364,240 | $407,659 | $450,727 | $493,447 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 8, 2024 | Nov 8, 2024 |
| 10-K | Annual report | Oct 25, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Other events
|
Oct 22, 2024 | Oct 22, 2024 |
| 10-Q | Quarterly report | May 24, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Feb 22, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Nov 22, 2023 | Sep 30, 2023 |
All 297 Procyon Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.